Literature DB >> 12170607

Catechol-o-methyltransferase in rat erythrocyte and three other tissues: comparison of biochemical properties after removal of inhibitory calcium.

D R Quiram1, R M Weinshilboum.   

Abstract

The biochemical characteristics of soluble catechol-O-methyltransferase (COMT) activity in rat erythrocytes were compared with the properties of the soluble enzyme in rat liver, heart, and brain. COMT was measured by a procedure that avoided artifacts of some other assay procedures including inhibition of the enzyme by endogenous calcium. After the removal of calcium from the reaction mixture the apparent Michaelis-Menten constants for the two cosubstrates of the COMT reaction, S-adenosyl-1-methionine (SAM) and 3,4-dihydroxybenzoic acid (DBA), were similar in tissue preparations of rat liver, brain, heart and blood. The apparent Km values for the four tissues ranged from 5.7 to 6.7 x 10(-6) M and from 0.9-1.4 x 10(-4) M for SAM and DBA, respectively. The optimal pH and the optimal concentration of magnesium for the assay of red blood cell COMT were also similar to those for the enzyme in the three other rat tissues. After the removal of endogenous calcium, COMT activity in all four tissues was inhibited by the addition of calcium, and the [CaCl2] necessary to inhibit the enzyme activity 50% was 3-5 x 10(-4) M in all cases. The relative activities of COMT in the rat heart, brain, erythrocyte, and liver when expressed per g tissue or per ml of packed red blood cells were 1 to 1.15 to 1.58 to 140, respectively.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 12170607     DOI: 10.1111/j.1471-4159.1976.tb00327.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  6 in total

Review 1.  Interaction of alcohol with other drugs and nutrients. Implication for the therapy of alcoholic liver disease.

Authors:  C S Lieber
Journal:  Drugs       Date:  1990       Impact factor: 9.546

Review 2.  Neurogenic aspects of essential hypertension in man.

Authors:  G A FitzGerald
Journal:  Ir J Med Sci       Date:  1979-12       Impact factor: 1.568

3.  Anti-catechol-O-methyltransferase: demonstration of specificity and immunological cross-reactivity with the enzyme from rat liver, kidney, brain, and choroid plexuses.

Authors:  G P Kaplan; B K Hartman; C R Creveling
Journal:  Neurochem Res       Date:  1980-08       Impact factor: 3.996

4.  Inheritance of low erythrocyte catechol-o-methyltransferase activity in man.

Authors:  R M Weinshilboum; F A Raymond
Journal:  Am J Hum Genet       Date:  1977-03       Impact factor: 11.025

5.  Catechol-O-methyltransferase inhibition by U-0521 increases striatal utilization of levodopa.

Authors:  A Reches; D Jiang; S Fahn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-07       Impact factor: 3.000

6.  A radioenzymatic assay of catechol-O-methyltransferase in hair root cells: comparison with erythrocyte activity.

Authors:  J J Hoo; T Strohmeyer; W J Beckermann; D P Agarwal; H W Goedde
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.